Table 1.
Patient, tumor, and treatment characteristics
| Characteristic (n = 37) | No. (percent) |
|---|---|
| Age (y) | |
| Mean | 53 |
| Standard deviation | 14.80 |
| Sex | |
| Female | 19 (51) |
| Male | 18 (49) |
| KPS | |
| ≥90 | 32 (87) |
| 80 | 3 (8) |
| 70 | 2 (5) |
| MGMT∗ | |
| Methylated | 6 (16) |
| Unmethylated | 4 (11) |
| Unknown | 27 (73) |
| Received adjuvant TMZ | 32 (86) |
| Surgery type | |
| Biopsy | 6 (16) |
| Subtotal resection | 16 (43) |
| Gross total resection | 15 (41) |
| Dose (Gy) | |
| Median | 75 |
| Range | 66-81 |
Abbreviations: KPS = Karnofsky Performance Status; MGMT = O6-methylguanine-DNA methyltransferase; TMZ, temozolomide.
∗
Ten patients with available data.